MBRX - Moleculin Biotech Inc
IEX Last Trade
2.57
0.030 1.167%
Share volume: 9,312
Last Updated: Fri 30 Aug 2024 09:13:16 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.54
0.03
1.18%
Summary score
14%
Profitability
0%
Dept financing
9%
Liquidity
50%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.57%
Return on assets
-14.38%
Return on sales
0%
Return on invested capital
-75.76%
Total debt ratio
24.94%
Debt ratio change over timeo
-2%
Current Ratio
3.87%
Quick Ratio
0%
Cash Position Ratio
3.48%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.71%
Return on assets
-17.45%
Return on sales
0%
Return on invested capital
-196.74%
Total debt ratio
41.51%
Debt ratio change over timeo
-2.27%
Current Ratio
3.75%
Quick Ratio
0%
Cash Position Ratio
3.12%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-64.7%
Return on assets
-16.04%
Return on sales
0%
Return on invested capital
-128.13%
Total debt ratio
50.19%
Debt ratio change over time
-4.51%
Current Ratio
5.28%
Quick Ratio
0%
Cash Position Ratio
4.48%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
2.31%
Return on assets
-41.62%
Return on sales
0%
Return on invested capital
176.75%
Total debt ratio
-200.19%
Debt ratio change over time
-2%
Current Ratio
-23.51%
Quick Ratio
0%
Cash Position Ratio
-22.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MBRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.57% | -3.05% | 11.55% | 6.27% |
| Return on assets | -14.38% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -75.76% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 24.94% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -2% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 3.75% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.12% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 25% | 53% | 56% |
| Short-term ratios | MBRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.71% | -25.62% | 17.94% | 7.14% |
| Return on assets | -17.45% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -196.74% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 41.51% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -2.27% | -23.44% | 9.66% | 0.6% |
| Dept financing | 10% | 25% | 45% | 8% |
| Current Ratio | 3.75% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.12% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 43% | 35% | 60% |